rigel pharmaceuticals inc
(RIGL:Consolidated Issue Listed on Nasdaq Glbl Slct Mrkt)
As of 4:30 PM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).
Key News About rigel pharmaceuticals inc
No news article found for RIGL.
| Recently Viewed | |||
| RIGL:US | $4.71 USD | +0.07 |  |
| Company | Last | Change |
| Cell Therapeutics Inc | $1.24 USD | +0.02 |
| View Industry Companies | ||
Industry Analysis
RIGL
Industry Average
| Valuation | RIGL | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 269.6x |
|
| Price/Book | 1.5x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 87.9x |
|
Post a JobJobs
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact RIGEL PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
